George W. Lloyd
EVP, Investments & CLO · Royalty Pharma plc
- 2025
- Dec 5, 2025
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies George W. Lloyd files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M in RPRX purchases and sales in the last 12 months
- Christopher Hite - $27.36M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
- Gregory Norden - $161K in RPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is George W. Lloyd?
George W. Lloyd is a corporate insider, tracked as EVP, Investments & CLO of Royalty Pharma plc (RPRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did George W. Lloyd last file a Form 4?
The most recent primary Form 4 on record is dated 5 December 2025, one of 4 filings going back to 2025.
Has George W. Lloyd been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($9.57M) across all tracked filings.
